Summary of clinical and laboratory data of study subjects with and without DCE-MRI plaque measurements in the AIM-HIGH clinical trial | Zendy

Kevin D. O’Brien | Zendy; Daniel S. Hippe | Zendy; Huijun Chen | Zendy; Moni B. Neradilek | Zendy; Jeffrey L. Probstfield | Zendy; Suzanne Peck | Zendy; Daniel Isquith | Zendy; Gádor Cantón | Zendy; Chun Yuan | Zendy; Nayak L. Polissar | Zendy; Xue-Qiao Zhao | Zendy; William Kerwin | Zendy

Open Access

Summary of clinical and laboratory data of study subjects with and without DCE-MRI plaque measurements in the AIM-HIGH clinical trial

Author(s) -

Kevin D. O’Brien,

Daniel S. Hippe,

Huijun Chen,

Moni B. Neradilek,

Jeffrey L. Probstfield,

Suzanne Peck,

Daniel Isquith,

Gádor Cantón,

Chun Yuan,

Nayak L. Polissar,

Xue-Qiao Zhao,

William Kerwin

Publication year - 2016

Publication title -

data in brief

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.122

H-Index - 30

ISSN - 2352-3409

DOI - 10.1016/j.dib.2015.12.030

Subject(s) - medicine , magnetic resonance imaging , vascularity , clinical trial , radiology

This brief data article summarizes the clinical risk factors and laboratory data of a group of subjects recruited for the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes) and an associated magnetic resonance imaging (MRI) substudy. The sample is restricted to those on statin therapy at the time of enrollment and data are presented stratified by whether dynamic contrast enhanced MRI (DCE-MRI) markers of carotid plaque vascularity and inflammation were available or not. The data provided herein are directly related to the article "Longer Duration of Statin Therapy is Associated with Decreased Carotid Plaque Vascularity by Magnetic Resonance Imaging" [2].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research